150 related articles for article (PubMed ID: 34153277)
41. The role of sphingosine 1 phosphate in coronary artery disease and ischemia reperfusion injury.
Mihanfar A; Nejabati HR; Fattahi A; Latifi Z; Pezeshkian M; Afrasiabi A; Safaie N; Jodati AR; Nouri M
J Cell Physiol; 2019 Mar; 234(3):2083-2094. PubMed ID: 30341893
[TBL] [Abstract][Full Text] [Related]
42. Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization.
Deng S; Zhou X; Ge Z; Song Y; Wang H; Liu X; Zhang D
Int J Biochem Cell Biol; 2019 Sep; 114():105564. PubMed ID: 31276786
[TBL] [Abstract][Full Text] [Related]
43. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation.
Fang R; Zhang LL; Zhang LZ; Li W; Li M; Wen K
Arch Med Res; 2017 Feb; 48(2):147-155. PubMed ID: 28625317
[TBL] [Abstract][Full Text] [Related]
44. Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation.
Olesch C; Ringel C; Brüne B; Weigert A
Mediators Inflamm; 2017; 2017():6059203. PubMed ID: 28848247
[TBL] [Abstract][Full Text] [Related]
45. Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology.
Rohrbach T; Maceyka M; Spiegel S
Crit Rev Biochem Mol Biol; 2017 Oct; 52(5):543-553. PubMed ID: 28618839
[TBL] [Abstract][Full Text] [Related]
46. Sphingosine 1-phosphate (S1P) suppresses the collagen-induced activation of human platelets via S1P4 receptor.
Onuma T; Tanabe K; Kito Y; Tsujimoto M; Uematsu K; Enomoto Y; Matsushima-Nishiwaki R; Doi T; Nagase K; Akamatsu S; Tokuda H; Ogura S; Iwama T; Kozawa O; Iida H
Thromb Res; 2017 Aug; 156():91-100. PubMed ID: 28609704
[TBL] [Abstract][Full Text] [Related]
47. Hydrogen peroxide induces S1P1 receptors and sensitizes vascular endothelial cells to sphingosine 1-phosphate, a platelet-derived lipid mediator.
Igarashi J; Miyoshi M; Hashimoto T; Kubota Y; Kosaka H
Am J Physiol Cell Physiol; 2007 Feb; 292(2):C740-8. PubMed ID: 16943246
[TBL] [Abstract][Full Text] [Related]
48. Sphingosine-1-phosphate receptor 3 signaling.
Li Q; Li Y; Lei C; Tan Y; Yi G
Clin Chim Acta; 2021 Aug; 519():32-39. PubMed ID: 33811927
[TBL] [Abstract][Full Text] [Related]
49. S1PR1 Tyr143 phosphorylation downregulates endothelial cell surface S1PR1 expression and responsiveness.
Chavez A; Schmidt TT; Yazbeck P; Rajput C; Desai B; Sukriti S; Giantsos-Adams K; Knezevic N; Malik AB; Mehta D
J Cell Sci; 2015 Mar; 128(5):878-87. PubMed ID: 25588843
[TBL] [Abstract][Full Text] [Related]
50. S1PR1 (Sphingosine-1-Phosphate Receptor 1) Signaling Regulates Blood Flow and Pressure.
Cantalupo A; Gargiulo A; Dautaj E; Liu C; Zhang Y; Hla T; Di Lorenzo A
Hypertension; 2017 Aug; 70(2):426-434. PubMed ID: 28607130
[TBL] [Abstract][Full Text] [Related]
51. Sphingosine 1-phosphate signaling in ischemia and reperfusion injury.
Raza Z; Saleem U; Naureen Z
Prostaglandins Other Lipid Mediat; 2020 Aug; 149():106436. PubMed ID: 32173486
[TBL] [Abstract][Full Text] [Related]
52. Sphingosine-1-phosphate signaling in the cardiovascular system.
Peters SL; Alewijnse AE
Curr Opin Pharmacol; 2007 Apr; 7(2):186-92. PubMed ID: 17280869
[TBL] [Abstract][Full Text] [Related]
53. An engineered S1P chaperone attenuates hypertension and ischemic injury.
Swendeman SL; Xiong Y; Cantalupo A; Yuan H; Burg N; Hisano Y; Cartier A; Liu CH; Engelbrecht E; Blaho V; Zhang Y; Yanagida K; Galvani S; Obinata H; Salmon JE; Sanchez T; Di Lorenzo A; Hla T
Sci Signal; 2017 Aug; 10(492):. PubMed ID: 28811382
[TBL] [Abstract][Full Text] [Related]
54. Hepatopoietin Cn reduces ethanol-induced hepatoxicity via sphingosine kinase 1 and sphingosine 1-phosphate receptors.
Liu Y; Saiyan S; Men TY; Gao HY; Wen C; Liu Y; Zhou X; Wu CT; Wang LS; Cui CP
J Pathol; 2013 Aug; 230(4):365-76. PubMed ID: 23839903
[TBL] [Abstract][Full Text] [Related]
55. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
[TBL] [Abstract][Full Text] [Related]
56. Lysophospholipids in coronary artery and chronic ischemic heart disease.
Abdel-Latif A; Heron PM; Morris AJ; Smyth SS
Curr Opin Lipidol; 2015 Oct; 26(5):432-7. PubMed ID: 26270808
[TBL] [Abstract][Full Text] [Related]
57. Sphingosine 1-phosphate receptor 1 regulates the directional migration of lymphatic endothelial cells in response to fluid shear stress.
Surya VN; Michalaki E; Huang EY; Fuller GG; Dunn AR
J R Soc Interface; 2016 Dec; 13(125):. PubMed ID: 27974574
[TBL] [Abstract][Full Text] [Related]
58. Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.
Polzin A; Piayda K; Keul P; Dannenberg L; Mohring A; Gräler M; Zeus T; Kelm M; Levkau B
J Mol Cell Cardiol; 2017 Sep; 110():35-37. PubMed ID: 28709768
[TBL] [Abstract][Full Text] [Related]
59. The functional roles of S1P in immunity.
Hisano Y; Nishi T; Kawahara A
J Biochem; 2012 Oct; 152(4):305-11. PubMed ID: 22923732
[TBL] [Abstract][Full Text] [Related]
60. Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors.
Waeber C; Blondeau N; Salomone S
Drug News Perspect; 2004; 17(6):365-82. PubMed ID: 15334188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
